These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20513315)

  • 1. A comparison of dosing accuracy: visually impaired and sighted people using insulin pens.
    Williams AS; Schnarrenberger PA
    J Diabetes Sci Technol; 2010 May; 4(3):514-21. PubMed ID: 20513315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical aspects of insulin pen devices.
    Pearson TL
    J Diabetes Sci Technol; 2010 May; 4(3):522-31. PubMed ID: 20513316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating low vision and nonvisual instructions for diabetes technology: an empirically validated process.
    Williams AS
    J Diabetes Sci Technol; 2012 Mar; 6(2):252-9. PubMed ID: 22538133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis: including visually impaired participants in validation design studies of diabetes technology.
    Uslan M; Blubaugh M
    J Diabetes Sci Technol; 2010 Sep; 4(5):1236-7. PubMed ID: 20920445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of symposium articles on insulin pen devices and alternative insulin delivery methods.
    Dang DK; Lee J
    J Diabetes Sci Technol; 2010 May; 4(3):558-61. PubMed ID: 20513320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind.
    Heinemann L; Drossel D; Freckmann G; Kulzer B
    J Diabetes Sci Technol; 2016 Nov; 10(6):1382-1387. PubMed ID: 27605593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned during the development of HumaPen memoir, an insulin pen with a memory feature.
    Breslin SD; Ignaut DA; Boyd DE
    J Diabetes Sci Technol; 2010 May; 4(3):540-6. PubMed ID: 20513318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studies.
    Friedrichs A; Basso N; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1179-84. PubMed ID: 22027314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing accuracy of two insulin pre-filled pens.
    Asakura T; Seino H; Kageyama M; Yohkoh N
    Curr Med Res Opin; 2008 May; 24(5):1429-34. PubMed ID: 18400146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin pens: the modern delivery devices.
    Baruah MP
    J Assoc Physicians India; 2011 Apr; 59 Suppl():38-40. PubMed ID: 21823254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Economic, and Patient-Reported Benefits of Connected Insulin Pen Systems: A Systematic Literature Review.
    Cranston I; Jamdade V; Liao B; Newson RS
    Adv Ther; 2023 May; 40(5):2015-2037. PubMed ID: 36928495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the dosing accuracy of commonly used disposable insulin pens.
    Krzywon M; van der Burg T; Fuhr U; Schubert-Zsilavecz M; Abdel-Tawab M
    Diabetes Technol Ther; 2012 Sep; 14(9):804-9. PubMed ID: 22694223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.
    Hyllested-Winge J; Jensen KH; Rex J
    Clin Drug Investig; 2010; 30(10):643-74. PubMed ID: 20701399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.
    Klonoff DC; Nayberg I; Stauder U; Oualali H; Domenger C
    J Diabetes Sci Technol; 2017 May; 11(3):623-630. PubMed ID: 27898389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart Pens Will Improve Insulin Therapy.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2018 May; 12(3):551-553. PubMed ID: 29411641
    [No Abstract]   [Full Text] [Related]  

  • 17. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.
    Hermanns N; Kulzer B; Haak T
    Diabetes Technol Ther; 2008 Aug; 10(4):322-7. PubMed ID: 18715206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin pens for treatment of diabetes].
    Bärtsch U; Comtesse Ch; Wetekam B
    Ther Umsch; 2006 Jun; 63(6):398-404. PubMed ID: 16841576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.